Rapid response with good toleration of sirolimus for life‐threatening neonatal lymphatic malformations
ABSTRACT Introduction Lymphatic malformations (LMs) are rare vascular anomalies predominantly affecting infants, which can be debilitating or life‐threatening when complicated with intralesional bleeding or infection. Effective and safe management strategies are essential in such cases. Case present...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-09-01
|
Series: | Pediatric Investigation |
Subjects: | |
Online Access: | https://doi.org/10.1002/ped4.12397 |
_version_ | 1827813637565186048 |
---|---|
author | Shixiao Dong Li Li Jiaosheng Xu Zhonglong Han Xia Zheng |
author_facet | Shixiao Dong Li Li Jiaosheng Xu Zhonglong Han Xia Zheng |
author_sort | Shixiao Dong |
collection | DOAJ |
description | ABSTRACT Introduction Lymphatic malformations (LMs) are rare vascular anomalies predominantly affecting infants, which can be debilitating or life‐threatening when complicated with intralesional bleeding or infection. Effective and safe management strategies are essential in such cases. Case presentation We report a case series involving four Chinese neonates with life‐threatening LMs, initially treated with oral sirolimus. All patients achieved rapid relief and sustained remission, using a lower sirolimus dosage than previously recommended. Furthermore, adverse events were rarely recorded during follow‐up. Conclusion Sirolimus can be considered a promising choice for neonates with intricate and life‐threatening LMs. Initiation with a reduced sirolimus dose is advisable. |
first_indexed | 2024-03-11T23:33:47Z |
format | Article |
id | doaj.art-740158f604f3440fbf0d025bdad80bc3 |
institution | Directory Open Access Journal |
issn | 2574-2272 |
language | English |
last_indexed | 2024-03-11T23:33:47Z |
publishDate | 2023-09-01 |
publisher | Wiley |
record_format | Article |
series | Pediatric Investigation |
spelling | doaj.art-740158f604f3440fbf0d025bdad80bc32023-09-20T05:30:03ZengWileyPediatric Investigation2574-22722023-09-017320621110.1002/ped4.12397Rapid response with good toleration of sirolimus for life‐threatening neonatal lymphatic malformationsShixiao Dong0Li Li1Jiaosheng Xu2Zhonglong Han3Xia Zheng4Department of Neonatology, Neonatal Center, Beijing Children's Hospital Capital Medical University, National Center for Children's Health Beijing ChinaDepartment of Dermatology, Plastic Surgery Hospital Chinese Academy of Medical Sciences Beijing ChinaDepartment of Dermatology, Beijing Children's Hospital Capital Medical University, National Center for Children's Health Beijing ChinaDepartment of Radiology, Beijing Children's Hospital Capital Medical University, National Center for Children's Health Beijing ChinaDepartment of Neonatology, Neonatal Center, Beijing Children's Hospital Capital Medical University, National Center for Children's Health Beijing ChinaABSTRACT Introduction Lymphatic malformations (LMs) are rare vascular anomalies predominantly affecting infants, which can be debilitating or life‐threatening when complicated with intralesional bleeding or infection. Effective and safe management strategies are essential in such cases. Case presentation We report a case series involving four Chinese neonates with life‐threatening LMs, initially treated with oral sirolimus. All patients achieved rapid relief and sustained remission, using a lower sirolimus dosage than previously recommended. Furthermore, adverse events were rarely recorded during follow‐up. Conclusion Sirolimus can be considered a promising choice for neonates with intricate and life‐threatening LMs. Initiation with a reduced sirolimus dose is advisable.https://doi.org/10.1002/ped4.12397DosageLymphatic malformationsNeonatesSirolimus |
spellingShingle | Shixiao Dong Li Li Jiaosheng Xu Zhonglong Han Xia Zheng Rapid response with good toleration of sirolimus for life‐threatening neonatal lymphatic malformations Pediatric Investigation Dosage Lymphatic malformations Neonates Sirolimus |
title | Rapid response with good toleration of sirolimus for life‐threatening neonatal lymphatic malformations |
title_full | Rapid response with good toleration of sirolimus for life‐threatening neonatal lymphatic malformations |
title_fullStr | Rapid response with good toleration of sirolimus for life‐threatening neonatal lymphatic malformations |
title_full_unstemmed | Rapid response with good toleration of sirolimus for life‐threatening neonatal lymphatic malformations |
title_short | Rapid response with good toleration of sirolimus for life‐threatening neonatal lymphatic malformations |
title_sort | rapid response with good toleration of sirolimus for life threatening neonatal lymphatic malformations |
topic | Dosage Lymphatic malformations Neonates Sirolimus |
url | https://doi.org/10.1002/ped4.12397 |
work_keys_str_mv | AT shixiaodong rapidresponsewithgoodtolerationofsirolimusforlifethreateningneonatallymphaticmalformations AT lili rapidresponsewithgoodtolerationofsirolimusforlifethreateningneonatallymphaticmalformations AT jiaoshengxu rapidresponsewithgoodtolerationofsirolimusforlifethreateningneonatallymphaticmalformations AT zhonglonghan rapidresponsewithgoodtolerationofsirolimusforlifethreateningneonatallymphaticmalformations AT xiazheng rapidresponsewithgoodtolerationofsirolimusforlifethreateningneonatallymphaticmalformations |